INTERFERON BETA-1A for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7,473 adverse event reports in the FDA FAERS database where INTERFERON BETA-1A was used for Product used for unknown indication.
Most Reported Side Effects for INTERFERON BETA-1A
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 5,931 | 8.8% | 45 | 3,123 |
| Influenza like illness | 4,475 | 6.6% | 12 | 861 |
| Memory impairment | 3,468 | 5.1% | 3 | 547 |
| Multiple sclerosis | 3,412 | 5.1% | 185 | 960 |
| Fatigue | 3,164 | 4.7% | 11 | 736 |
| Fall | 3,128 | 4.6% | 48 | 1,571 |
| Gait disturbance | 3,031 | 4.5% | 18 | 892 |
| Death | 2,766 | 4.1% | 2,765 | 127 |
| Pain | 2,692 | 4.0% | 19 | 677 |
| Headache | 2,533 | 3.8% | 8 | 667 |
| Drug ineffective | 2,238 | 3.3% | 19 | 449 |
| Injection site pain | 2,132 | 3.2% | 2 | 356 |
| Malaise | 2,000 | 3.0% | 24 | 510 |
| Pyrexia | 1,688 | 2.5% | 21 | 574 |
| Hypoaesthesia | 1,685 | 2.5% | 5 | 490 |
Other Indications for INTERFERON BETA-1A
Multiple sclerosis (56,475)
Relapsing-remitting multiple sclerosis (2,058)
Maternal exposure timing unspecified (245)
Relapsing multiple sclerosis (192)
Secondary progressive multiple sclerosis (89)
Covid-19 (31)
Primary progressive multiple sclerosis (27)
Exposure via father (20)
Progressive multiple sclerosis (19)
Paternal exposure timing unspecified (18)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)